Restricted expression of FcγRIII (CD16) in synovium and dermis: Implications for tissue targeting in rheumatoid arthritis (RA)

Clinical and Experimental Immunology

Volumn 108, Issue 3, 1997, Pages 401-406

  Edwards, J C W ^a,b   Blades, S ^a   Cambridge, G ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b Rheumatology Unit   (United Kingdom)

Author keywords

CD16; fetal; macrophage; rheumatoid arthritis; synovium

Indexed keywords

FC RECEPTOR;

ADULT; ANTIGEN ANTIBODY COMPLEX; ARTICLE; DERMIS; FETUS; GENE EXPRESSION; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYNOVIUM;

EID: 0030981016     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1997.3941286.x     Document Type: Article

References (29)

1. Maini RN, Zvaifler NJ. Rheumatoid arthritis. In: Klippel J, Deppe P, eds. Rheumatology. London: Mosby Year Book Europe, 1994:3.1.1-3.15.16.
2. Kimberley RP, Urowitz MB. Systemic lupus erythematosus. In: Klippel J, Dieppe P, eds. Rheumatology. London: Mosby Year Book Europe, 1994:6.1.1-6.7.20.
3. Moxley G, Ruddy S. Immune complexes and complement. Kelly's textbook of rheumatology, 4th edn. Philadelphia: WB Saunders, 1993:188-97.
4. van de Winkel JGJ, Capel PJA. Human IgG Fc receptor heterogeneity. Immunol Today 1993; 14:215-21.
5. Edwards JCW. The nature and origins of synovium. J Anat 1994; 184:493-501.
6. Bröker BM, Edwards JCW, Fanger MW, Ldyard PM. The prevalence and distribution of macrophages bearing FcγRI, FcγRII and FcγRIII in synovium. Scand J Rheumatol 1990; 19:123-35.
7. Ravetch JV, Perussia B. Alternative membrane forms of FcγRIII on human NK cells and neutrophils. J Exp Med 1989; 170:481-97.
8. Anderson CL, Looney JR. Human leukocyte IgG receptors. Immunol Today 1986; 7:264-6.
9. Nagarajan S, Chesla S, Cobern L, Anderson P, Zhu C, Selvaraj P. Ligand binding and phagocytosis by CD16 isoforms. J Biol Chem 1995; 270:25762-70.
10. Wong HL, Welch GR, Brandes ME, Wahl SM. IL-4 antagonizes induction of Fc gamma RIII (CD16) expression by transforming growth factor-beta on human monocytes. J Immunol 1991; 147: 1843-8.
11. Wahl SM, Allen JB, Welch GR, Wong HL. Transforming growth factor-β in synovial fluids modulates FcγRIII (CD16) expression on mononuclear phagocytes. J Immunol 1992; 148:485-90.
12. Tuijnman WB, Van Wichen DF, Schuurman HJ. Tissue distribution of human IgG Fc receptors CD16, CD32 and CD64: an immunohistochemical study. APMIS 1993; 101:319-29.
13. + macrophages in antitumor cytotoxicity. Lab Invest 1992; 67:166-74.
14. Edwards JCW, Wilkinson LS. Immunohistochemistry of synovium. In: Henderson B, Edwards JCW, Pettifer ER, eds. Mechanisms and models in rheumatoid arthritis. New York: Academic Press, 1995:133-50.
15. Fahre JW, Williams AF. Quantitative serological analysis of a rabbit anti-rat lymphocyte serum and preliminary biochemical characterisation of the major antigen recognised. Transplantation 1977; 23:349-59.
16. Medof ME, Walter EI, Rutgers JL, Knowles DM, Nussenzweig V. Identification of the complement decay accelerating factor on epithelium and glandular cells and in body fluids. J Exp Med 1987; 165:848-64.
17. Stevens CR, Mapp PI, Revell PA. A monoclonal antibody (Mab 67) marks type B synoviocytes. Rheumatol Int 1990; 10:103-6.
18. Edwards JCW. The synovium in rheumatology. In: Klippel J, Dieppe P, eds. Rheumatology, 2nd edn. London: Mosby Year Book Europe, 1997:5.6.1-5.6.8.
19. Edwards JCW, Wilkinson LS, Jones HM, Soothill P, Henderson KJ, Worrall JG, Pitsillides AA. The formation of human synovial joint cavities: a possible role for hyaluronan and CD44 in altered interzone cohesion. J Anat 1994; 185:355-67.
20. Tigalonowa M, Bjerke JR, Matre R. Fc gamma-receptors on Langerhans cells and keratinocytes in suspension from normal skin characterized using soluble immune complexes and monoclonal antibodies. Acta Derm Venereol 1991; 71:99-103.
21. Edwards JCW, Cambridge G. Is rheumatoid arthritis a failure of B cell death in synovium? Ann Rheum Dis 1995; 54:696-700.
22. Lindhout E, Mevissen ML, Kwekkeboom JM, de Groot C. Direct evidence that human follicular dendritic cells rescue germinal centre B cells from death by apoptosis. Clin Exp Immunol 1993; 91:330-4.
23. McLennan IC. Germinal centres. Annu Rev Immunol 1994; 12:117-39.
24. Lampert IA, Schofield JB, Amlot P, Van Noorden S. Protection of germinal centres from complement attack. J Pathol 1993; 170:115-20.
25. Tarkowski A, Trollmo C, Seifert PS, Hansson GK. Expression of decay-accelerating (actor on synovial lining cells in inflammatory and degenerative arthritides. Rheumatol Int 1992; 12:201-5.
26. Mannik M, Nardella FA, Sasso EH. Rheumatoid factors in immune complexes of patients with rheumatoid arthritis. Springer Semin Immunopathol 1988; 10:215-21.
27. Børretzen M, Randen I, Natvig J, Thompson KM. Structural restriction in the heavy chain CDR3 of human rheumatoid factors. J Immunol 1995; 155:3630-7.
28. Palmer DG. The anatomy of the rheumatoid lesion. Br Med Bull 1995; 51:286-95.
29. Hamman J, Vogel B, van Schijndel MW, van Lier RAW. The seven span transmembrane receptor CD97 has a ligand (CD55, DAF). J Exp Med 1996; 184:1185-9.